Energenesis Biomedical CO.,LTD. (6657)’in fiyatı nedir?

Energenesis Biomedical CO.,LTD. (6657)’in fiyatı $0.97305026’dir

Energenesis Biomedical CO.,LTD. (6657)’in piyasa değeri nedir?

Energenesis Biomedical CO.,LTD. (6657)’in piyasa değeri $85.54M’dir.

Energenesis Biomedical CO.,LTD. (6657) Fiyat Geçmişi

Energenesis Biomedical CO.,LTD., a firm established in 2012 and headquartered in Taipei, Taiwan, is an active participant in the biomedicine sector. The company specializes in the development of a diverse range of medical solutions and research materials. Its primary pharmaceutical pipeline includes ENERGI-F703, which is currently undergoing Phase II clinical trials for the treatment of diabetic foot ulcers, and ENERGI-F701, a topical solution for addressing alopecia that is also in its second phase of clinical assessment. The comprehensive portfolio of therapeutic agents further encompasses: ENERGI-F711, formulated as a cream for burns. ENERGI-F702, designed to combat metabolic diseases. ENERGI-F704, targeting inflammatory bowel disease. ENERGI-F708, for the management of asthma. ENERGI-F705, aimed at controlling Parkinson's disease. ENERGI-F707, addressing mitochondrial deficiencies. ENERGI-F706, used to treat cachexia. ENERGI-F709, which serves as a vaccine adjuvant. ENERGI-F710, intended for the regulation of blood phosphate levels. Beyond its therapeutic developments, Energenesis Biomedical also provides a selection of scientific research products, including reagents for Western blotting, cell culture supplements, components for protein isolation and quantification, various laboratory dyes, and buffer solutions.

Yıl	Performans
2026 (TTM)	2.62%
2025	-16.78%
2024	-17.88%
2023	0.00%

Yıl

Performans

2026 (TTM)

2.62%

2025

-16.78%

2024

-17.88%

2023

0.00%

Şirket	Hisse fiyatı	Değişim 1yıl%	Ülke
Vertex Pharmaceuticals Incorporated VRTX.US	$547.71	38.62%	US
Argenx SE ARGX.US	$1.04K	58.06%	NL
Moderna, Inc. MRNA.US	$145.75	437.43%	US
CSL Limited CSL.AX	$118.70	-15.60%	AU
Lonza Group AG LONN.SW	$770.19	8.98%	CH

Şirket

Hisse fiyatı

Değişim 1yıl%

Ülke